organophosphonates has been researched along with Psoriasis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, L | 1 |
| Bourke, J; McAleer, MA | 1 |
| Cannizzaro, MV; Chimenti, S; Chiricozzi, A; Giunta, A; Nisticò, SP; Saraceno, R | 1 |
| Caro-Patón, A; Mata-Román, L; Núñez-Rodríguez, MH; Santamaría-Martínez, A | 1 |
| Alvarez Fuertes, G; González Barranco, D; Salazar Mallén, M | 1 |
2 review(s) available for organophosphonates and Psoriasis
| Article | Year |
|---|---|
[What's new in dermatological treatments?].
Topics: Adenine; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Cyclosporine; Dermatofibrosarcoma; Dermatologic Agents; Dermatology; Drug Therapy, Combination; Etanercept; Follow-Up Studies; Gels; HIV Infections; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Ipilimumab; Melanoma; Neoplasm Staging; Organophosphonates; Piperazines; Psoriasis; Pyrimidines; Receptors, Tumor Necrosis Factor; Skin Diseases; Skin Neoplasms; Survival Analysis; Tenofovir; Treatment Outcome; Ustekinumab | 2010 |
Complete resolution of erythrodermic psoriasis in an HIV and HCV patient unresponsive to antipsoriatic treatments after highly active antiretroviral therapy (Ritonavir, Atazanavir, Emtricitabine, Tenofovir).
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Hepatitis C, Chronic; HIV Infections; Humans; Immunocompromised Host; Male; Middle Aged; Oligopeptides; Organophosphonates; Psoriasis; Pyridines; Ritonavir; Tenofovir; Treatment Outcome | 2012 |
3 other study(ies) available for organophosphonates and Psoriasis
| Article | Year |
|---|---|
Intravenous cidofovir for resistant cutaneous warts in a patient with psoriasis treated with monoclonal antibodies.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Cidofovir; Cytosine; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Organophosphonates; Psoriasis; Treatment Outcome; Tumor Necrosis Factor-alpha; Warts | 2011 |
[Reactivation of hepatitis B treated with adefovir after infliximab administration].
Topics: Adenine; Antibodies, Monoclonal; Antiviral Agents; Hepatitis B; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Organophosphonates; Psoriasis; Recurrence | 2006 |
[Onchocerca dermatosis from Mexico and its therapy with metrifonate].
Topics: Adult; Biopsy; Body Weight; Diagnosis, Differential; Edema; Eosinophilia; Erythema; Humans; Keratosis; Leukocytosis; Male; Mexico; Onchocerciasis; Organophosphonates; Psoriasis; Skin | 1970 |